You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Because he says he "can't resist a good sale," PCMag's Dan Costa was one of many who sent spit in to 23andMe during the direct-to-consumer genetic profiling firm's $0 down, $9 per month subscription fee offer.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.
A new analysis suggests the B.1.1.7 strain of SARS-CoV-2 could be deadlier than previous ones, according to the Guardian.
NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.
In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.